ArticleJournal of the American Heart Association2025
Safety and Efficacy of Endovascular Thrombectomy for Acute Ischemic Stroke After Cardiac Surgery: A Retrospective Analysis of Readmission Nationwide Database Data.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThere is limited evidence regarding outcomes of endovascular thrombectomy (EVT) in patients with acute ischemic stroke after cardiac surgery (CS). Therefore, we aimed to evaluate the outcomes of EVT in patients with acute ischemic stroke attributable to CS. METHODS AND
resultsThe data of retrospective study was obtained from the National Readmission Database between 2016 and 2020. Patients with acute ischemic stroke who received EVT within 7 days after CS were compared with 2 groups: those who did not receive EVT after CS (Analysis-1) and those who received EVT without CS (Analysis-2). The primary outcome was functional outcome determined by discharge disposition. Propensity score matching was employed to minimize covariate imbalance and subgroup analyses were conducted by type of CS. In the total cohort, 983 patients received EVT treatment after CS, 43 578 patients had non-EVT treatment after CS, and 66 829 patients received EVT treatment without CS. In the Analysis-1 outcomes after matching, the EVT treatment after CS had a lower poor functional outcome (57.6% versus 63.7%,
conclusionsFavorable findings of short-term functional outcomes demonstrate that EVT is likely an effective and acceptable treatment modality for patients with acute ischemic stroke following CS. However, the risk of intracranial hemorrhage remains a concern in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.